Health
Study shows reliability and robustness of injectable anti-obesity medication – News-Medical.Net
A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing…
A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug. With obesity affecting more than 40 percent of American adults, the findings could have a major impact on weight management in primary care and other settings. The study is published today in the Journal of the American Medical Association.
The 68-week study was conducted at 41 sites in the…
-
Noosa News21 hours agoOnly person charged over Spear Creek murders admits he lied to police
-
Noosa News22 hours agoAllegedly armed man who sparked hours-long lockdown of Brisbane City Botanic Gardens in custody
-
General9 hours agoCopper Coast Council threatens ratepayer with legal action over ‘offensive’ comment
-
Noosa News24 hours agoMan armed with knife shuts down Botanic Gardens